Back to Top
Briakinumab Biosimilar - Dylight®488 Research Grade
Briakinumab Biosimilar - Research Grade: Dylight®488
Conjugate:
Dylight®488
Target:
CD30
Clone:
n/a
Isotype:
Human IgG1(E356D/M358L)-Kappa
Host:
CHO Cells
Species Reactivity:
Human
Concentration:
0.2 mg/ml
Formulation:
This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Storage:
This DyLight® 488 conjugate is stable when stored at 2-8°C. Do not freeze.
